Iveta Grundmane

  • Citations Per Year
Learn More
PURPOSE To determine if a test formulation of latanoprost 0.005% (Bausch & Lomb) eyedrops reduced intraocular pressure (IOP) as well as Xalatan® (latanoprost 0.005%) in patients with ocular hypertension (OH) or primary open-angle glaucoma (POAG). METHODS This multicenter, randomized, investigator-masked, parallel-group study allocated 266 patients with OH(More)
  • 1